Factors Influencing the Decision to Provide General Anesthesia or Moderate Sedation for Treatment Related Procedures in Children with Cancer
|
Children’s Hospital of Philadelphia / Elizabeth Ely, PhD, RN |
Nurse Researcher Grants |
2007 |
Pennsylvania |
Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma
|
The Pennsylvania State University / Ken Lucas, MD |
Innovation Grants |
2006 |
Pennsylvania |
Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition
|
Children’s Hospital of Philadelphia / Yael Mossé, MD |
Reach Grants |
2013 |
Pennsylvania |
The role of overexpressed microRNA’s in the pediatric cancer rhabdomyosarcoma
|
University of Pennsylvania / Frederic Barr, MD, PhD |
Innovation Grants |
2007 |
Pennsylvania |
Alex's Lemonade Stand Foundation Center of Excellence in Childhood Cancer Drug Development and Clinical Pharmacology at The Children's Hospital of Philadelphia
|
Children’s Hospital of Philadelphia / Frank Balis, MD - Scholar: Emily Blauel, MD |
Center of Excellence Grants |
2013 |
Pennsylvania |
Drugging MYCN |
Children’s Hospital of Philadelphia / Yael Mossé, MD |
Crazy 8 Awards |
2020 |
Pennsylvania |
Impact of Pediatric Germline Testing in a Pediatric Cancer Predisposition Clinic |
Children’s Hospital of Philadelphia / Lisa Schwartz, PhD |
Psychosocial Family Impact Grant |
2018 |
Pennsylvania |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children’s Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Role of Myosin VI in Pediatric Glioma Proliferation and Invasion |
University of Pennsylvania / Monalisa Mukherjea |
Young Investigator Grants |
2012 |
Pennsylvania |
Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2016 |
Pennsylvania |